| AASLD

Liver immunology: A new section for the journal

Read more about Liver immunology: A new section for the journal

Ginny L. Bumgardner – 28 September 2017

A Large‐scale, multicenter serum metabolite biomarker identification study for the early detection of hepatocellular carcinoma

Read more about A Large‐scale, multicenter serum metabolite biomarker identification study for the early detection of hepatocellular carcinoma

Ping Luo, Peiyuan Yin, Rui Hua, Yexiong Tan, Zaifang Li, Gaokun Qiu, Zhenyu Yin, Xingwang Xie, Xiaomei Wang, Wenbin Chen, Lina Zhou, Xiaolin Wang, Yanli Li, Hongsong Chen, Ling Gao, Xin Lu, Tangchun Wu, Hongyang Wang, Junqi Niu, Guowang Xu – 28 September 2017 – Hepatocellular carcinoma (HCC) is the third most lethal cancer worldwide. The lack of effective biomarkers for the early detection of HCC results in unsatisfactory curative treatments. Here, metabolite biomarkers were identified and validated for HCC diagnosis.

Mitochondrial and anabolic pathways in hepatocellular carcinoma

Read more about Mitochondrial and anabolic pathways in hepatocellular carcinoma

Nikolai A. Timchenko – 28 September 2017

Acquired hemophilia A resolution in a hepatitis C virus/human immunodeficiency virus–coinfected patient with cure of hepatitis C by direct‐acting antiviral agents

Read more about Acquired hemophilia A resolution in a hepatitis C virus/human immunodeficiency virus–coinfected patient with cure of hepatitis C by direct‐acting antiviral agents

Laetitia Mauge, Juliette Pavie, Dominique Batisse, Luc Darnige – 28 September 2017

Reply

Read more about Reply

Alessandro Soria, Giuseppe Lapadula, Massimiliano Fabbiani, Andrea Gori – 27 September 2017

Zooming in on liver zonation

Read more about Zooming in on liver zonation

Daniel J. Felmlee, Dominic Grün, Thomas F. Baumert – 27 September 2017

Portal pressure and liver stiffness measurements in the prediction of fibrosis regression after sustained virological response in recurrent hepatitis C

Read more about Portal pressure and liver stiffness measurements in the prediction of fibrosis regression after sustained virological response in recurrent hepatitis C

Ezequiel Mauro, Gonzalo Crespo, Carla Montironi, Maria‐Carlota Londoño, Virginia Hernández‐Gea, Pablo Ruiz, Lydia Sastre, Julissa Lombardo, Zoe Mariño, Alba Díaz, Jordi Colmenero, Antoni Rimola, Juan Carlos Garcia‐Pagán, Mercé Brunet, Xavier Forns, Miquel Navasa – 27 September 2017 – Sustained virological response (SVR) improves survival in post‐liver transplant (LT) recurrent hepatitis C. However, the impact of SVR on fibrosis regression is not well defined.